Work

Phase II trial of edatrexate in relapsed or refractory germ cell tumors: A Southwest Oncology Group study (SWOG 9124)

Year: 1998

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1023/a:1006128024879

Authors: Frederick J. Meyers, Danika Lew, Primo N. Lara, Steve Williamson, Ernest Marshall, Stanley P. Balcerzak, Saul E. Rivkin, Wolfram Samlowski, E. David Crawford

Institutions: UC Davis Comprehensive Cancer Center, University of California, Davis, SWOG Cancer Research Network, University of Kansas Medical Center, Southeastern Medical Oncology Center, The Ohio State University Wexner Medical Center, The Ohio State University, University of Utah, University of Colorado Denver

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G2064543036, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, G3350348941, Southwest Oncology Group Treatment Grant, G763325562, Southwest Oncology Group/University of California, Davis

OpenAlex ID: W243759879

FWCI: 0.37

Cites: 16

Cited by: 6

Related to: 10